Genomics Infotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 15-12-2024
- Paid Up Capital ₹ 1.00 M
as on 15-12-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2016
About Genomics Infotech
The Company is engaged in the Service Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Genomics Infotech Private Limited India is Prasanna Shastry as CEO. Raja Pujari, Vijay Laxmi, Rajet Kumar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U72300UP2015PTC074286
- Company No.
074286
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 2015
- Date of AGM
01 Dec 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Genomics Infotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasanna Shastry  | CEO | 01-Feb-2016 | Current |
| Raja Pujari | Managing Director | 04-Nov-2015 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prasanna Shastry | Additional Director and Ceo | 18-Apr-2016 | Current |
| Vijay Laxmi | Director | 04-Nov-2015 | Current |
| Rajet Kumar | Additional Director | 03-Jan-2017 | Current |
| Yajnanarayana Udupa | Additional Director | 15-Dec-2016 | Current |
| Vinay Suresh | Additional Director | 15-Dec-2016 | Current |
Financial Performance of Genomics Infotech.
Enhance accessibility to Genomics Infotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Genomics Infotech?
In 2016, Genomics Infotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Genomics Formulations Private LimitedActive 9 years 2 months
Raja Pujari, Vijay Laxmi and 3 more are mutual person
- R Manglam Micro Credit AssociationActive 9 years 4 months
Raja Pujari and Vijay Laxmi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genomics Infotech?
Unlock and access historical data on people associated with Genomics Infotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genomics Infotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomics Infotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
